Your support for Team Remission Possible will fund research at Fred Hutch and give new hope to Myeloma patients .
I am facing my third relapse and am refractory to 5 lines of treatment now. RESEARCH IS SO IMPORTANT!
I hope to qualify for a NEW CAR T med called anito-cel that is currently in trials and that should be available this coming fall. In the meantime we wait as my labs go up and probably have to get some difficult other chemo like cytoxin.
I am participating in the 2026 Defeat Multiple Myeloma Run/Walk on Sunday, June 28.
Please join me for my 12th year participating in this fight. You can increase our impact by joining me on the walk or making a donation to my page today; (in March donation ending in $26, or $0.26 will be matched.)
100% of all funds raised will go directly to advancing multiple myeloma cancer research at Fred Hutchinson Cancer Research Center.
Each donation plays a part in bringing myeloma treatment options to patients faster and helping fund research to find a cure for this cancer. Together, we are building community, supporting survivors, remembering loved ones lost, and funding research that is giving new hope to patients. We are committed, we are strong, and our impact can be enormous.
What is Multiple Myeloma?
Multiple Myeloma is a cancer of plasma cells found in bone marrow. Normal plasma cells help the immune system fight disease, but when plasma cells become cancerous they grow out of control and can produce a tumor called a plasmacytoma. If someone has more than one plasmacytoma, they have multiple myeloma.
Why support this event?
Defeat Multiple Myeloma’s mission is to raise awareness of multiple myeloma while supporting research that seeks to discover new treatments, improve the quality of life for myeloma patients, and ultimately find a cure for this devastating form of cancer. Funds from the 2024 Defeat Multiple Myeloma event will continue to support immunotherapy research and clinical trials at Fred Hutch which are using CAR-T cells and have shown very promising early results for patients.
